http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2022076410-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7c18ba6b5a2e42fbc7fc3017f50a6bb6 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate | 2020-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3aae89a3c32d1ddec6b26edb7183345 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4937903d6db1b0c93948503dbef3470e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f906a196d28a57630408b1945880b45 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a0486247bb56e07ac65d3093e62e619 |
| publicationDate | 2022-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2022076410-A |
| titleOfInvention | Diagnostic marker for malignant peripheral nerve sheath tumor |
| abstract | PROBLEM TO BE SOLVED: To provide a useful means for discriminating between a malignant peripheral nerve sheath tumor and a neurofibromatosis. A subject is malignant, comprising detecting at least one of insulin-like growth factor 2-mRNA-binding protein 2 (IGF2BP2) and paradine in a specimen taken from a subject's neural tumor lesion. A method for assessing the likelihood of having a peripheral nerve sheath tumor. A test kit for use in the diagnosis of malignant peripheral nerve sheath tumor containing at least one of a specific antibody against IGF2BP2 and a specific antibody against paradin. [Selection diagram] Fig. 1 |
| priorityDate | 2020-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 296.